In this year’s fight for majority control of the General Assembly, abortion has emerged as a key issue and a bright-line distinction between Republican and Democratic candidates for the Virginia House and Senate. Republican Gov. Glenn Youngkin, whose Spirit of...
Earlier this year, a narrow abortion rights majority in the Virginia state Senate blocked the passage of all proposed abortion bans and restrictions. It was an amazing victory that took the fierce advocacy of those who lobbied against the bills and was reinforced...
Two years ago, when I retired after serving 20 years in the United States Air Force, there was no question where I would put down my final roots: Virginia. As a Virginia Beach native, the Commonwealth is home, but it’s also one of the best places to live for...
Although these pharmacies dispensing the drug marks a victory for reproductive freedom, a looming Supreme Court case could cut off access to the medication in states where abortion is still legal.
Just weeks before Virginians go to the polls to elect the next General Assembly, Data for Progress has released new polling in the state’s most competitive legislative districts that illustrates voters’ lack of trust in Republicans on the issue of reproductive...
The Republican presidential primary field is full of anti-abortion candidates, but amid massive electoral backlash to abortion bans, some candidates are attempting to backpedal or soften their stances on the campaign trail, or ignore the issue altogether.
Two candidates in a key Fredericksburg-area Virginia House seat faced off recently in a lively debate that brought Republican Lee Peters’ views on banning abortion to the forefront. In the forum with Democratic candidate Josh Cole, Peters committed to the 15-week...
A source familiar with the governor’s plans says that passing a 15-week abortion ban will be his legislative priority if Republicans win majority control of the state House and Senate in this fall’s elections.
Opill is the first ever birth control pill to be approved for over-the-counter sales. The medication will likely become available at stores and online retailers in the U.S. in early 2024.
Women have suffered through ectopic pregnancies, miscarriages, fetal anomalies, and other complications, but have found it difficult to get the care they need due to restrictive abortion bans.
